Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma

BACKGROUND: Molecular markers predicting survival in esophageal adenocarcinoma (EAC) are rare. Specifically, in favorable oncologic situations, e.g. nodal negativity or major neoadjuvant therapy response, there is a lack of additional risk factors that serve to predict patients’ outcome more precise...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Schiffmann, Lars M., Göbel, Heike, Löser, Heike, Schorn, Fabian, Werthenbach, Jan Paul, Fuchs, Hans F., Plum, Patrick S., Bludau, Marc, Zander, Thomas, Schröder, Wolfgang, Bruns, Christiane J., Kashkar, Hamid, Quaas, Alexander, Gebauer, Florian
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545033/
https://ncbi.nlm.nih.gov/pubmed/31151416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5722-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items